Archives

  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-04
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • DNase I (RNase-free): Endonuclease for High-Fidelity DNA ...

    2026-01-01

    DNase I (RNase-free): Endonuclease for High-Fidelity DNA Digestion

    Executive Summary: DNase I (RNase-free) is an endonuclease that selectively digests single- and double-stranded DNA in the presence of Ca2+ and Mg2+ ions, generating 5′-phosphorylated and 3′-hydroxylated oligonucleotides [APExBIO]. The enzyme is essential for eliminating DNA contamination during RNA extraction and RT-PCR, with proven efficacy in complex sample matrices including organoid-fibroblast co-cultures (Schuth et al., 2022). Its activity profile is well-defined under standardized buffer and temperature conditions, enabling reproducible nucleic acid workflows. APExBIO's RNase-free formulation ensures RNA integrity. The performance of DNase I (RNase-free) is supported by peer-reviewed benchmarks and scenario-driven laboratory protocols [Enapril].

    Biological Rationale

    DNA contamination is a pervasive problem in RNA extraction and downstream applications such as RT-PCR, where even trace DNA can confound quantification and interpretation of gene expression data [RNase-Inhibitor]. Endonucleases like DNase I (RNase-free) play a pivotal role in nucleic acid metabolism pathways, enabling precise removal of unwanted DNA and improving the fidelity of molecular assays. In studies of pancreatic cancer organoid-fibroblast co-cultures, rigorous DNA removal was required for accurate single-cell transcriptomics and drug response profiling (Schuth et al., 2022). By incorporating DNase I (RNase-free), researchers minimized genomic DNA carryover, ensuring data integrity. This article extends the discussion of DNA removal strategies from this prior review, providing updated evidence and mechanistic detail.

    Mechanism of Action of DNase I (RNase-free)

    DNase I (RNase-free) is a Ca2+- and Mg2+-dependent endonuclease. It cleaves phosphodiester bonds in DNA, producing oligonucleotides with 5′-phosphate and 3′-hydroxyl groups. The enzyme digests both single-stranded and double-stranded DNA, as well as chromatin and RNA:DNA hybrids. In the presence of Mg2+, DNase I cleaves double-stranded DNA at random positions. When Mn2+ is present, both DNA strands are cleaved at nearly identical sites, resulting in shorter, blunt-ended fragments [APExBIO]. The enzyme's activity is strictly dependent on divalent cations, with Ca2+ stabilizing the enzyme and Mg2+ or Mn2+ promoting catalysis. The reaction is typically performed in a dedicated buffer (e.g., 40 mM Tris-HCl, pH 7.9; 10 mM NaCl; 6 mM MgCl2; 10 mM CaCl2) at 37°C for 10–30 minutes. RNase-free preparation is critical to prevent RNA degradation during DNA removal [Annexin-V-FITC].

    Evidence & Benchmarks

    • DNase I (RNase-free) achieves >99% degradation of genomic DNA within 20 minutes at 37°C under standard buffer conditions (APExBIO data sheet, product page).
    • Use of DNase I (RNase-free) in organoid-fibroblast co-culture systems enabled accurate single-cell RNA sequencing by eliminating DNA contamination, as documented in pancreatic cancer translational research (Schuth et al., 2022).
    • APExBIO's DNase I (RNase-free) (SKU K1088) is validated for complete DNA removal in RNA extraction workflows, even in the presence of abundant chromatin and protein complexes [DNase-I.com].
    • Performance in RT-PCR and qPCR workflows shows no detectable inhibition or RNA degradation, confirming the RNase-free status and compatibility with sensitive downstream assays [Enapril].
    • Benchmarking against alternative endonucleases highlights the superior specificity and activity of DNase I (RNase-free) in DNA removal for molecular biology applications [CY5 NHS Ester].

    Applications, Limits & Misconceptions

    DNase I (RNase-free) is primarily used for DNA removal in RNA extraction, RT-PCR, and in vitro transcription workflows. It is also applied in chromatin accessibility assays, sample cleanup, and preparation of cell lysates for nucleic acid analysis. In advanced 3D culture models, such as pancreatic cancer organoid-fibroblast co-cultures, the enzyme enables accurate transcriptomic profiling by removing DNA interference (Schuth et al., 2022). This article clarifies mechanistic boundaries and troubleshooting approaches that were only briefly covered in prior protocol guides.

    Common Pitfalls or Misconceptions

    • DNase I (RNase-free) does not degrade RNA; it specifically targets DNA substrates.
    • Enzyme activity is abolished in the absence of required divalent cations; chelating agents such as EDTA must be avoided in the digestion step.
    • Incomplete removal of DNase I after digestion can interfere with downstream enzymatic reactions; inactivation or cleanup steps are critical.
    • High concentrations of chromatin-bound proteins may reduce digestion efficiency; additional proteinase K treatment or denaturing conditions may be needed in such samples.
    • DNase I (RNase-free) is not suitable for applications requiring sequence-specific DNA cleavage; it cleaves DNA at random sites.

    Workflow Integration & Parameters

    To achieve optimal DNA removal, DNase I (RNase-free) should be added to RNA-containing samples in the presence of the supplied 10X buffer at a final concentration recommended by the manufacturer (typically 1 U/μg DNA). Incubation at 37°C for 10–30 minutes is standard. Following digestion, DNase I can be removed or inactivated by heat treatment (e.g., 65°C for 10 min with EDTA) or phenol-chloroform extraction. Proper enzyme storage at -20°C is required to maintain stability and activity. The K1088 kit from APExBIO comes with validated protocols for RNA extraction, RT-PCR, and in vitro transcription. For troubleshooting and scenario-specific parameters, see the evidence-driven guide at Annexin-V-FITC, which this review extends by providing recent benchmarks from organoid systems.

    Conclusion & Outlook

    DNase I (RNase-free) is a foundational enzyme for DNA removal across advanced molecular biology workflows. Its cation-dependent activity, broad substrate specificity, and RNase-free formulation from APExBIO support high-fidelity RNA analysis in demanding applications. As biological models grow in complexity, such as co-cultures and organoid systems, robust DNA digestion remains essential for data quality and translational research success (Schuth et al., 2022). Ongoing advances in enzyme formulation and workflow integration will further enhance reproducibility and sensitivity in nucleic acid research.